Related Experiment Videos
Statistical approaches to effectiveness measurement and outcome-driven re-randomizations in the Clinical
Sonia M Davis1, Gary G Koch, C E Davis
1Quintiles, Inc., 5927 South Miami Boulevard, Morrisville, NC 27560, USA. sonia.davis@quintiles.com
Abstract:
The design of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia and Alzheimer's disease studies pose several statistical challenges, including issues related to performing multiple comparisons, defining effectiveness outcomes, and collecting and analyzing data from a design with multiple outcome-driven re-randomizations. We discuss the CATIE strategy for addressing many hypotheses within the context of one clinical trial while controlling the overall type I error rate. We provide motivation for the use of two effectiveness outcomes: time to all-cause discontinuation and composite endpoints that combine outcomes from multiple domains, such as efficacy, safety, cost-effectiveness, and quality of life. Methods for statistical analysis of an outcome-driven re-randomization trial are compared and evaluated. We describe analysis within each phase, analysis based on the first randomization or treatment algorithms, and repeated measures modeling. Finally, strategies are described for designing an electronic data collection system for trials with repeated outcome-driven re-randomizations.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Randomized Experiments
Simple randomization
Simple...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Blinding
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs